Invitrogen™ Human CALHM1 Synthetic Peptide
CALHM1 Synthetic Peptide, PEP-1009, from Invitrogen.
- Gene ID (Enter)
- 255022
- Species
- Human
- Purification method
- Purified
- Accession number
- Q8IU99
- Common name
- Human CALHM1
- Brand
- Invitrogen
CALHM1 Synthetic Peptide, PEP-1009, from Invitrogen.
CALHM1 Synthetic Peptide, PEP-1009, from Invitrogen.
Alzheimers disease (AD) is a progressive neurodegenerative disorder characterized by a massive loss of neurons in several brain regions and by the presence of senile plaques comprised of aggregated amyloid-beta (Abeta) peptides produced by the endoproteolysis of the amyloid precursor protein (APP). The calcium homeostasis modulator 1 (CALHM1) is a recently identified multipass transmembrane glycoprotein that controls cytosolic Ca2+ concentration and Abeta levels. While some studies suggest CALHM1 is significantly associated with risk of AD, other reports suggest there is no link. CALHM1 has been suggested to modulate the Ca2+-dependent proteolytic process of APP through controlling the level of cytosolic Ca2+.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15255009 |
| Specifications | |
| Gene ID (Enter) | 255022 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q8IU99 |
| Common name | Human CALHM1 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | CALHM1 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1009 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |